Abbott | ABT - Debt

Stock Price
109.04
Daily Change
0.84 0.78%
Monthly
-14.67%
Yearly
-14.96%
Q1 Forecast
105.93

Abbott reported $12.94B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Agilent USD 3.41B 640M Jun/2025
AtriCure USD 77.25M 15.39M Jun/2025
Baxter International USD 9.73B 584M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Boston Scientific USD 12.05B 19M Sep/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Dexcom USD 2.45B 132.5M Sep/2025
Edwards Lifesciences USD 702.6M 3.2M Jun/2025
Globus Medical USD 121.1M 120.63M Jun/2025
Hologic USD 2.63B 104.3M Sep/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 45.8B 4.97B Sep/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 28.61B 93M Jun/2025
Merit Medical Systems USD 820.55M 89.88M Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Smith & Nephew USD 3.32B 334M Dec/2024
Solventum Corp USD 7.91B 97M Mar/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.01M 94.67M Jun/2025
Teleflex USD 2B 180.08M Jun/2025
Terumo JPY 174.84B 14.98B Mar/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Zimmer Biomet Holdings USD 8.11B 540.1M Sep/2025